UNSPSC 51282102: Amantocillin

This classification denotes a penicillin antibiotic with the molecular formula C19H27N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, GV5ZHU20H9 chemically known as 6-(3-amino-1-adamantanecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as amantocillin, which bears US NIH Compound Identifier 168908. European Medicines Agency schedules Amantocillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05391MIG.

UNSPSC 51282102 Amantocillin is a Commodity code for a specific antibiotic pharmaceutical product. Recent state and local procurement activity under this code shows minimal direct solicitation; the few opportunities posted reference antibiotic and antimicrobial procurement through piggyback contracts and pharmaceutical vendor agreements. State and local agencies — primarily state health departments and county health authorities — use this code when purchasing amantocillin as part of broader pharmaceutical stockpiles, emergency preparedness programs, or routine medical supply orders. The work involves securing reliable supply of the drug product through competitive bidding processes, often leveraging cooperative purchasing vehicles such as MMCAP or regional pharmaceutical consortia to negotiate volume discounts and streamline procurement cycles.

Activity appears concentrated in Florida and Illinois, based on recent posted opportunities. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract to Chartwell Rx LLC through the MMCAP Infuse consortium (IFB 26482DPHPREPDB53392, closed August 2026), though the actual products awarded were doxycycline and ciprofloxacin, not amantocillin; Seminole County, Florida issued an IFB for naloxone and drug deactivation systems (IFB60459723LAS, response deadline July 26, 2023), which similarly does not align with amantocillin procurement. The code shows little recent relevant activity — opportunities posted under it do not match the nominal scope of amantocillin supply, suggesting either infrequent direct procurement of this specific drug or systematic tagging misalignment in recent state and local solicitations.